Jove
Visualize
Contáctanos
JoVE
x logofacebook logolinkedin logoyoutube logo
ACERCA DE JoVE
Visión GeneralLiderazgoBlogCentro de Ayuda JoVE
AUTORES
Proceso de PublicaciónConsejo EditorialAlcance y PolíticasRevisión por ParesPreguntas FrecuentesEnviar
BIBLIOTECARIOS
TestimoniosSuscripcionesAccesoRecursosConsejo Asesor de BibliotecasPreguntas Frecuentes
INVESTIGACIÓN
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchivo
EDUCACIÓN
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualCentro de Recursos para ProfesoresSitio de Profesores
Términos y Condiciones de Uso
Política de Privacidad
Políticas

Videos de Conceptos Relacionados

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.6K
Tumor Immunotherapy01:27

Tumor Immunotherapy

1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
Cancer Therapies02:49

Cancer Therapies

9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K
Mesenchymal Stem Cells01:19

Mesenchymal Stem Cells

5.5K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
5.5K
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

4.6K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.6K

También podría leer

Artículos Relacionados

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por
Same author

Preclinical characterization and phase 1 clinical testing of targeting mitochondrial peroxiredoxin 3 in cancer.

Nature communications·2026
Same author

Durable Response to Sotorasib Plus Panitumumab in NRAS G12C-Mutated, Microsatellite Instability-High (MSI-H) Rectal Cancer Refractory to Immunotherapy.

Cureus·2026
Same author

Real-World Outcomes and Progression Patterns with First-Line Osimertinib in Patients with Advanced <i>EGFR</i>-Mutant Non-Small Cell Lung Cancer: A Nationwide Turkish Oncology Group Study.

Cancers·2026
Same author

Dose-Adjusted EPOCH-R in Aggressive B-Cell Lymphomas: Efficacy, Molecular Prognostic Factors, and Real-World Outcomes from a Multicenter Turkish Cohort-A Turkish Oncology Group (TOG) Study.

Medicina (Kaunas, Lithuania)·2026
Same author

Real-World Outcomes of CDK4/6 Inhibitors in Germline BRCA1/2-Mutated Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer: Turkish Oncology Group (TOG) Study.

Current oncology (Toronto, Ont.)·2026
Same author

Epidemiology and Clinical Profiles of <i>Bacteroides fragilis</i> Bacteremia in a Tertiary Care Setting: A 5-Year Review.

The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale·2026

Video Experimental Relacionado

Updated: Jan 14, 2026

Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma
07:55

Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma

Published on: April 11, 2018

14.9K

Terapia celular en el sarcoma: panorama actual y direcciones futuras

Taha Koray Sahin1, Theodora Germetaki2, Deniz Can Guven1

  • 1Department of Medical Oncology, Hacettepe University Cancer Institute, Ankara, Turkey.

Journal for immunotherapy of cancer
|January 12, 2026
PubMed
Resumen

Las terapias celulares muestran una gran promesa para el tratamiento de sarcomas raros, ofreciendo respuestas duraderas. Los desafíos incluyen la identificación de objetivos específicos y la superación del microambiente tumoral para una aplicación más amplia.

Palabras clave:
Terapia celular adoptiva - ACTReceptor de antígeno quimérico - CARInmunoterapiaReceptor de células T - TCRLinfocitos infiltrantes de tumores - TIL

Más Videos Relacionados

Tumorsphere Derivation and Treatment from Primary Tumor Cells Isolated from Mouse Rhabdomyosarcomas
09:21

Tumorsphere Derivation and Treatment from Primary Tumor Cells Isolated from Mouse Rhabdomyosarcomas

Published on: September 13, 2019

7.6K
Isolation and Characterization of Tumor-initiating Cells from Sarcoma Patient-derived Xenografts
07:18

Isolation and Characterization of Tumor-initiating Cells from Sarcoma Patient-derived Xenografts

Published on: June 13, 2019

7.4K

Videos de Experimentos Relacionados

Last Updated: Jan 14, 2026

Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma
07:55

Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma

Published on: April 11, 2018

14.9K
Tumorsphere Derivation and Treatment from Primary Tumor Cells Isolated from Mouse Rhabdomyosarcomas
09:21

Tumorsphere Derivation and Treatment from Primary Tumor Cells Isolated from Mouse Rhabdomyosarcomas

Published on: September 13, 2019

7.6K
Isolation and Characterization of Tumor-initiating Cells from Sarcoma Patient-derived Xenografts
07:18

Isolation and Characterization of Tumor-initiating Cells from Sarcoma Patient-derived Xenografts

Published on: June 13, 2019

7.4K

Área de la Ciencia:

  • Oncología
  • Inmunoterapia
  • Terapia Celular

Sus antecedentes:

  • Los sarcomas son tumores mesenquimales raros y heterogéneos con una respuesta limitada a los tratamientos convencionales.
  • Los inhibidores de puntos de control inmunitario muestran una eficacia mínima en muchos subtipos de sarcoma.
  • La terapia celular, en particular la terapia de células T con receptor de células T (TCR-T), está emergiendo como una estrategia de tratamiento viable.

Objetivo del estudio:

  • Revisar el panorama actual y el potencial futuro de diversas terapias celulares en el tratamiento de sarcomas.
  • Destacar los avances recientes y las aprobaciones en la terapia celular del sarcoma.
  • Identificar los desafíos que dificultan la aplicación generalizada de las terapias celulares en los sarcomas.

Principales métodos:

  • Revisión de la literatura actual sobre terapias celulares para sarcomas.
  • Análisis de diferentes modalidades de terapia celular que incluyen TCR-T, CAR-T, TILs, células NK y MSCs.
  • Discusión de las barreras biológicas y clínicas para una terapia celular eficaz del sarcoma.

Principales resultados:

  • Las terapias de células T con TCR modificadas genéticamente dirigidas a MAGE-A4 han mostrado respuestas duraderas en el sarcoma sinovial.
  • La aprobación de afamitresgene autoleucel (TCR-T) marca un paso significativo para la terapia celular en tumores sólidos.
  • Se están explorando múltiples tipos de terapia celular para el tratamiento del sarcoma.

Conclusiones:

  • Las terapias celulares ofrecen una vía prometedora para el tratamiento del sarcoma, y las aprobaciones recientes demuestran su potencial.
  • Superar desafíos como la falta de objetivos específicos, la heterogeneidad tumoral y el microambiente inmunosupresor es crucial.
  • Se necesita más investigación y una evaluación cuidadosa de la viabilidad clínica, la logística y la relación costo-efectividad para una implementación exitosa.